GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
FOR 15+ YEARS—
the most prescribed immune globulin (IG)*
*Based on combined data: internal calculations by Takeda based on Marketing Research Bureau (MRB) database of total IG Units prescribed over a combined 15 years (between 2005 and 2022).
GAMMAGARD LIQUID is the most used treatment for PI, with over 15 years of real-world experience and over a million infusions.
*Based on combined data: internal calculations by Takeda based on Marketing Research Bureau (MRB) database of total IG Units prescribed over a combined 15 years (between 2005 and 2022).
What about effectiveness and safety?
GAMMAGARD LIQUID helped prevent infections, and most side effects were considered mild to moderate. Here are the results that showed how many infections and side effects were experienced by people in the study.
A study of 61 patients showed:
There were no cases of validated acute serious bacterial infections (ASBIs) in patients treated with intravenous (IV) GAMMAGARD LIQUID.
*A patient-year is a patient experience in a clinical trial over the course of 1 year.
381 of the 400 non-serious side effects reported in patients treated with IV GAMMAGARD LIQUID were considered mild (217) to moderate (164). The remaining 5% (19) were severe.
Side effects may occur with IV treatment. Please click below for more details about the most common side effects.
Get inspiration on how infusing
GAMMAGARD LIQUID could fit into your life